Image of Statin Treatment in Patients With Intracerebral Hemorrhage

LITERATURE

Statin Treatment in Patients With Intracerebral Hemorrhage


Ever since the publication of the SPARCL trial (Stroke Prevention by Aggressive Reduction in Cholesterol Levels) in 2006, neurologists became aware of the fact that statins may increase the risk for future intracerebral hemorrhage
(ICH) in patients with previous ischemic stroke or ICH.1,2 At the same time, observational studies reported an
increased risk for hemorrhagic transformation or even symptomatic bleeding in ischemic stroke patients undergoing
thrombolysis who were pretreated with statins


Availability

REQJ668-01Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Stroke. 2018;49:00-00
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous